Auven Therapeutics
North America, Florida, United States, Delray Beach
Description
Auven Therapeutics is a private equity company focused on the healthcare industry.
Investor Profile
Auven Therapeutics has made 9 investments, with 0 in the past 12 months and 22% as lead.
Stage Focus
- Series A (33%)
- Series E (22%)
- Private Equity (11%)
- Series D (11%)
- Series B (11%)
- Series C (11%)
Country Focus
- Switzerland (67%)
- United States (22%)
- United Kingdom (11%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Medical
- Biopharma
- Therapeutics
- Oncology
- Pharmaceutical
- Health Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
